Skip to main content
Internal Medicine logoLink to Internal Medicine
. 2019 Jan 10;58(9):1295–1299. doi: 10.2169/internalmedicine.2232-18

The Early Diagnosis of Endophthalmitis Due to Group B Streptococcus Infective Endocarditis and Its Clinical Course: A Case Report and Literature Review

Yutaka Aoyama 1, Yusuke Oba 1, Satoshi Hoshide 1, Yusuke Arai 2, Takahiro Komori 1, Tomoyuki Kabutoya 1, Kazuomi Kario 1
PMCID: PMC6543214  PMID: 30626848

Abstract

A 68-year-old Japanese man was admitted to our hospital with right eye pain, a sudden worsening of his eyesight, and a fever. He was diagnosed with endogenous bacterial endophthalmitis due to infectious endocarditis (IE) of Group B Streptococcus (GBS) on the day of admission. He recovered systemically, but his right eye became phthisical only with the administration of antibiotics. We conducted a review of the reported cases of IE caused by GBS complicated with endogenous bacterial endophthalmitis. IE should be considered when an undetermined etiology of endogenous endophthalmitis is encountered. The prompt diagnosis and treatment of IE will improve patients' outcomes.

Keywords: endophthalmitis, infectious endocarditis, Group B Streptococcus

Introduction

Infective endocarditis (IE) is associated with subsequent morbidity and mortality, possibly due in part to one or more end-organ complications. Group B Streptococcus (GBS) is a rare cause of IE, but IE cases due to GBS are characterized by an acute onset and high mortality (1). Endophthalmitis is an emergency disease in the field of ophthalmology, and its endogenous bacterial etiology is rare (2,3). We experienced a rare case in which we were able to diagnose IE caused by GBS from the initial diagnosis of endogenous bacterial endophthalmitis; a relatively good course was obtained. We herein report the details of this case and those of our systematic review of previous cases of IE caused by GBS complicated with endogenous bacterial endophthalmitis.

Case Report

A 68-year-old Japanese man with hypertension, benign prostatic hyperplasia, and chronic kidney disease was admitted to our hospital with right eye pain and suddenly worsened eyesight that had persisted for 4 days. He had also been experiencing a fever and cloudiness of urine for eight days before admission. At admission, he was febrile (39℃) and showed a Levine III/VI systolic murmur at the apex. His right eye had a hypopyon and fibrin in the anterior chamber (Fig. 1A), and it exhibited conjunctival edema and was bloodshot. A funduscopic examination showed a Roth spot of the left eye (Fig. 1B). He was diagnosed with right endogenous bacterial endophthalmitis. No Osler's nodes, Janeway lesions, or splinter hemorrhaging was observed.

Figure 1.

Figure 1.

A: The right eye had a hypopyon (black arrow) and fibrin (white arrow) in the anterior chamber, conjunctival edema, and was bloodshot. B: The left eye had a Roth spot (black arrow).

A laboratory investigation revealed an increased neutrophil count of 14,941/μL and a C-reactive protein (CRP) level of 15.1 mg/dL, serum creatinine at 6.2 mg/dL, estimated glomerular filtration rate (eGFR) of 8 mL/min/1.73 m2, and bacterial urine. Because he had no history of trauma, we suspected IE as the cause of endogenous bacterial endophthalmitis. Transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) a demonstrated 12-mm vegetation at the posterior mitral leaflet (PML) (Fig. 2A) and an aortic valve loop abscess (Fig. 2B) along with severe mitral valve regurgitation (MR) due to P3 prolapse. The patient's case met two major and two minor Dukes criteria, so we made a diagnosis of IE. Blood cultures grew GBS.

Figure 2.

Figure 2.

A: Transesophageal echocardiography (TEE) demonstrated a 12-mm vegetation (*) at the posterior mitral leaflet (PML) and prolapse (**) at the PML. B: TEE demonstrated an aortic valve loop abscess (*).

Because the patient had been using urine catheters due to enlarged prostate disease, we speculated that the cause of IE might be urinary tract infection, which resulted in the occurrence of endogenous bacterial endophthalmitis as one of systemic embolism due to IE. We began treatment with intravitreal ceftriaxione 2 g and vancomycin 1.25 g on the day of admission. The patient was treated with intravenous ceftriaxione for 6 weeks; he avoided open surgery and enucleation of the eyeball. He recovered systemically, but the right eye became phthisical (Fig. 3).

Figure 3.

Figure 3.

The use of antibiotics and serial changes in the patient’s body temperature and CRP. CRP: C-reactive protein

Systematic Review

We reviewed the relevant literature to identify other reported cases of endophthalmitis due to infectious endocarditis caused by GBS. We performed a systematic survey of the Pub-Med database and the Japan Medical Abstracts Society database using the key words “endogenous endophthalmitis”, “infectious endocarditis” and “Group B Streptococcus”. We identified nine cases: three in Asia and six in Western countries (Table) (4-10). The average age of the 9 patients (4 men and 5 women) was 60.1 years (range 42-80 years). Two patients (22%) had hypertension (HT), 1 (11%) had congestive heart failure (CHF), and 4 (44%) had no significant underlying chronic disease. The presumed source of infection included urinary tract infection (UTI) and septic arthritis (2 patients; 22%), pharyngitis (1 patient; 11%), and cellulitis (1 patient; 11%), other sources were unknown.

Table.

Systematic Review: English, Japanese and Korean Studies of Cases of Endophthalmitis Due to Infectious Endocarditis Caused by GBS.

Reference Country Age/
sex
Patient history Initial TTE TEE Time to diagnosis of IE Time to treatment Systemic symptoms Eye symptoms Infection root Treatment Systemic outcome Visual outcome
4 U.S. 42/M CHF Unknown Unknown Unknown 2 months Fever, chills, sore throat Blurred vision Pharyngitis Intravenous antibiotics Died Died
5 ENG 42/M Unknown Unknown Unknown Unknown Unknown Fever, altered mental status Unknown Unknown Enucleation, AVR Remission Phthisis bulbi (rt.)
6 KOR 43/F None + Day 7 24 days 2 weeks Skin abscess Blurred vision, eye pain Cellulitis Intravenous antibiotics, vitrectomy Remission Phthisis bulbi (rt.)
7 JPN 53/F None - - 24 days 8 days Fever Eye pain, blurred vision Unknown Intravenous antibiotics, vitrectomy Remission Phthisis bulbi (lt.)
Our patient JPN 65/M HT, BPH, CKD + Day 1 9 days 9 days Fever, cloudiness of urine Floaters, eye pain, blurred vision UTI Intravenous antibiotics Remission Phthisis bulbi (rt.)
8 ENG 65/M DM - - 8 days 4 days Pain & swelling of the right knee Blurred vision Septic arthritis Intravenous antibiotics, intravitreal antibiotics, MVR+CABG Remission Phthisis bulbi (bi.)
9 U.S. 75/F None + Day 7 19 days 12 days Joint pain, decreased mental status Blurred vision Septic arthritis Intravenous antibiotics Remission Visual loss (lt.)
8 ENG 76/F None - - 4 weeks 48 h Fever Blurred vision UTI Intravenous antibiotics Remission Visual loss (rt.)
10 ENG 80/F Af, HT, DLp, post knee replacement - - On autopsy 2 weeks Knee pain Blurred vision, eye pain Unknown None Died Died

Af: atrial fibrillation, AVR: aortic valve replacement, BPH: benign prostatic hyperplasia, CABG: coronary artery bypass grafting, CHF: chronic heart failure, CKD: chronic kidney disease, DM: diabetes mellitus, DLp: dislipidemia, ENG: England, GBS: group B streptococcus, HT: hypertension, IE: infectious endocarditis, JPN: Japan, KOR: Korea, MVR: mitral valve replacement, TTE: transthoracic echocardiography, TEE: transesophageal echocardiography, UTI: urinary tract infection

The most frequent systemic symptom was a fever (5 patients; 44%). Other symptoms were joint pain and altered mental condition, chill, and sore throat. Our patient had only a fever. The most common eye symptom was blurred vision (8 patients; 89%), followed by eye pain (4 patients; 44%). Our patient also showed floaters.

The time of onset between the systemic infection and ocular manifestation was variable. Almost all of the patients, including our present patient, showed systemic symptoms first; only one patient showed the same onset times for systemic and ocular symptoms.

At admission, only three patients, including our patient, were suspected of having IE and had undergone TEE. In the other six patients, IE was not suspected, so TEE was not performed. Only our patient received the diagnosis of IE on the same day as the diagnosis of endogenous bacterial endophthalmitis. The time to treatment varied among the 9 patients: the earliest treatment was started within 48 hours, and the latest was 2 weeks after the onset of symptoms. All patients were treated with intravenous antibiotics; two patients underwent surgical therapy for their IE, and two patients underwent vitrectomy. Our patient achieved remission with only intravenous antibiotics. Two patients died, and the remaining seven achieved remission, but two patients lost their sight, and five patients developed phthisis bulbi.

Discussion

We experienced a rare case of a patient who had GBS IE from the initial diagnosis of endogenous bacterial endophthalmitis. His case was promptly diagnosed as IE, and antibiotics treatment resulted in a relatively benign outcome. This case was complicated with endogenous endophthalmitis as a bacterial embolism of IE. Endophthalmitis is an emergency disease in the field of ophthalmology, as it results in devastating ocular complications, such as blindness (11). Endogenous bacterial endophthalmitis is rare, but it has a higher mortality rate than other causes of endophthalmitis (12,13).

In their review, Sim et al. reported that the prevalence of endogenous bacterial endophthalmitis was 5-7% of all causes of endophthalmitis (6). Schiedler et al. reported that the prevalence of mortality in endogenous bacterial endophthalmitis was 29%, which was significantly higher than that of other types of endophthalmitis (11). Endogenous bacterial endophthalmitis caused by GBS is very rare. Generally, GBS is part of the normal bacterial flora of the skin, intestinal tract and vagina, which often leads to its infection in pregnant women (14). In non-pregnant patients with endogenous bacterial endophthalmitis, the reported proportion of endogenous bacterial endophthalmitis caused by GBS was only 5.2% (3). Our patient had been using urinary catheters due to enlarged prostate disease, so it is likely that the cause of his IE was a urinary tract infection.

Our patient's IE was due to GBS, which do not typically cause IE. The International Collaboration on Endocarditis-Prospective Cohort Study enrolled 2,781 patients with definite IE, and the proportions of cases of IE caused by different microorganisms was as follows: Staphylococcus aureus, 31%; viridans group, 17%; enterococci, 11%; and coagulase-negative Staphylococcus, 11% (15). Thus, although GBS is rarely responsible for IE, the onset of IE due to GBS is often acute and shows large vegetations with rapid valvular dysfunction, which results in a worse prognosis than with IE caused by other bacteria (1).

As noted above, IE complicated with endogenous endophthalmitis caused by GBS is very rare. We identified only nine cases, including our patient. He achieved remission with only intravenous antibiotics, whereas of the eight previous cases, six underwent cardiovascular surgery or vitrectomy, and the remaining two died. Our patient was immediately referred by the ophthalmologist to a cardiologist when endogenous endophthalmitis was diagnosed on the day of his admission. As a result, we were able to start antibiotics treatment for IE just nine days after the patient's eye symptoms started. This time period was significantly shorter than in most previous cases. Although the patient described by O'Brart et al. started treatment within eight days of eye-symptom onset, the patient eventually underwent cardiac surgery (8). That patient's case was complicated by diabetes mellitus; the immune system of individuals with diabetes is often impaired, making these individuals more susceptible to the development of a severe infection than those with intact systems.

In conclusion, we encountered a rare case of IE complicated with endogenous bacterial endophthalmitis due to GBS. Our patient's case suggests that IE should be considered when a patient with endogenous endophthalmitis of an undetermined etiology is encountered. The prompt diagnosis and treatment of IE can be expected to improve patients' outcomes.

The authors state that they have no Conflict of Interest (COI).

References

  • 1. Abdelghany M, Schenfeld L. Group B streptococcal infective endocarditis. J Infect Public Health 7: 237-239, 2014. [DOI] [PubMed] [Google Scholar]
  • 2. Okada AA, Johnson RP, Liles WC, et al. Endogenous bacterial endophthalmitis. Report of a ten-year retrospective study. Ophthalmology 101: 832-838, 1994. [PubMed] [Google Scholar]
  • 3. Jackson TL, Eykyn SJ, Graham EM, et al. Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases. Surv Ophthalmol 48: 403-423, 2003. [DOI] [PubMed] [Google Scholar]
  • 4. Farber BP, Weinbaum DL, Dummer JS. Metastatic bacterial endophthalmitis. Arch Intern Med 145: 62-64, 1985. [PubMed] [Google Scholar]
  • 5. Chihara S, Siccion E. Group B streptococcus endocarditis with endophthalmitis. Mayo Clin Proc 80: 74, 2005. [DOI] [PubMed] [Google Scholar]
  • 6. Sim YR, Lee YJ, Park SW, et al. Infective endocarditis presenting as endogenous endophthalmitis secondary to Streptococcus agalactiae in a healthy adult: case reports and literature review. Infect Chemother 49: 286-292, 2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Kobayashi K, Fujiseki Y, Takahashi K, et al. [Bacterial endopathalmitis caused by B streptococcus endocarditis]. Nippon Ganka Gakkai Zasshi (J Jpn Ophthalmol Soc) 110: 199-204, 2006. [PubMed] [Google Scholar]
  • 8. O'Brart DP, Eykyn SJ. Septicaemic infection with group B streptococci presenting with endophthalmitis in adults. Eye (Lond) 6 (Pt 4): 396-399, 1992. [DOI] [PubMed] [Google Scholar]
  • 9. Pokharel D, Doan AP, Lee AG. Group B streptococcus endogenous endophthalmitis presenting as septic arthritis and a homonymous hemianopsia due to embolic stroke. Am J Ophthalmol 138: 300-302, 2004. [DOI] [PubMed] [Google Scholar]
  • 10. Buglass TD, Romanchuk KG. Fatal case of group B streptococcal endogenous endophthalmitis. Can J Ophthalmol 30: 149-150, 1995. [PubMed] [Google Scholar]
  • 11. Schiedler V, Scott IU, Flynn HW, et al. Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am J Ophthalmol 137: 725-731, 2004. [DOI] [PubMed] [Google Scholar]
  • 12. Puliafito CA, Baker AS, Haaf J, et al. Infectious endophthalmitis. Review of 36 cases. Ophthalmology 89: 921-929, 1982. [PubMed] [Google Scholar]
  • 13. Bohigian GM, Olk RJ. Factors associated with a poor visual result in endophthalmitis. Am J Ophthalmol 15: 332-341, 1986. [DOI] [PubMed] [Google Scholar]
  • 14. Baker CJ. Group B streptococcal infections. Clin Perinatol 24: 59-70, 1997. [PubMed] [Google Scholar]
  • 15. Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 169: 463-473, 2009. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Internal Medicine are provided here courtesy of Japanese Society of Internal Medicine

RESOURCES